Clinical Impact of RANK Signalling in Ovarian Cancer

by Verena Wieser, Susanne Sprung, Irina Tsibulak, Johannes Haybaeck, Hubert Hackl, Heidelinde Fiegl, Christian Marth, Alain Gustave Zeimet
Published 2019-06-01

Association of TNFRSF10D DNA-Methylation with the Survival of Melanoma Patients

by Gudrun Ratzinger, Simone Mitteregger, Barbara Wolf, Regina Berger, Bernhard Zelger, Georg Weinlich, Peter Fritsch, Georg Goebel, Heidelinde Fiegl
Published 2014-07-01

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy

by Catherine Dold, Carles Rodriguez Urbiola, Guido Wollmann, Lisa Egerer, Alexander Muik, Lydia Bellmann, Heidelinde Fiegl, Christian Marth, Janine Kimpel, Dorothee von Laer
Published 2016-01-01

Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk.

by Mariana E De Araujo, Gertraud Erhart, Katharina Buck, Elisabeth Müller-Holzner, Michael Hubalek, Heidelinde Fiegl, Daniele Campa, Federico Canzian, Ursula Eilber, Jenny Chang-Claude, Stefan Coassin, Margot Haun, Lyudmyla Kedenko, Bernhard Paulweber, Roland Reitsamer, Irmgard Himmel, Dieter Flesch-Janys, Claudia Lamina, Florian Kronenberg, Lukas A Huber, Anita Kloss-Brandstätter
Published 2013-01-01